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Abstract
Background: Access to rehabilitation to prevent disability and optimise function is recommended for patients with
cancer, including following cancer diagnosis. Models to integrate rehabilitation within oncology services as cancer
treatment commences are required, but must be informed by those they are intended to support. We aimed to
identify views of patients, carers and clinicians to develop and refine a rehabilitation model to be tested in a
feasibility trial for people newly diagnosed with lung cancer or mesothelioma.
Methods: We conducted a focus group study with people affected by lung cancer or mesothelioma, their carers
and clinicians providing their care to identify priorities for rehabilitation in this period. We sought views on core
intervention components, processes and outcomes and integration with oncology services. Data were analysed
using thematic analysis.
Results: Fifteen clinicians (oncologists, nurse specialists, physiotherapists and occupational therapists), nine patients
and five carers participated. A proposed outline rehabilitation model was perceived as highly relevant for this
population. Participants recommended prompt and brief rehabilitation input, delivered whilst people attend for
hospital appointments or at home to maximise accessibility and acceptability. Participants recognised variation in
need and all prioritised tailored support for symptom self-management, daily activities and the involvement of
carers. Clinicians also prioritised achieving fitness for oncology treatment. Patients and carers prioritised a sensitive
manner of approach, positivity and giving hope for the future. Participant’s recommendations for outcome
measurement related to confidence in usual daily activities, symptom control and oncology treatment completion
rates over objective measures of cardiorespiratory fitness.
Conclusion: The importance of providing tailored rehabilitation around the time of diagnosis for people with lung
cancer or mesothelioma was affirmed by all participants. The refined model of rehabilitation recommended for
testing in a feasibility trial is flexible, tailored and short-term. It aims to support people to self-manage symptoms,
tolerate cancer treatments and to remain active and independent in daily life. It is delivered alongside scheduled
hospital appointments or at home by an expert practitioner sensitive to the psycho-social sequelae that follow a
diagnosis of thoracic cancer.
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Background
Rehabilitation following a diagnosis of cancer is recom-
mended to help people retain their functional independ-
ence during and after oncology treatment and to mitigate
subsequent disability [1]. Rehabilitation is defined as "a set
of measures that assist individuals who experience, or are
likely to experience, disability to achieve and maintain op-
timal functioning in interaction with their environment".
(http://www.who.int/disabilities/brochure_EN_2.pd-
f?ua=1). National and international cancer guidelines rec-
ommend that it is offered from the point of diagnosis.
Nonetheless, rehabilitation services are not always inte-
grated into cancer services, and there is a lack of data on
the feasibility and acceptability of rehabilitation models,
particularly in advanced cancer [2]. New models are needed
as despite compelling evidence of need relating to the phys-
ical, psychological, social and functional consequences of
diagnosis and treatment [3–6], people with thoracic cancer
may not be willing to access services [7–10]. Rehabilitation
trials in this population are predominantly exercise or
symptom self-management based and have not directly ad-
dressed participation in daily life activities in the period fol-
lowing diagnosis when people are at risk of deconditioning
[11]. To begin to address this, based on the literature, we
developed outline parameters for a comprehensive model
of rehabilitation. These included integration with oncology
services, delivery soon after diagnosis and tailored compo-
nents to support people maintain participation in daily ac-
tivities and minimise the onset of impairments as they
commence cancer treatment (see Fig. 1). To support
identification of environmental and personal factors
which may act as barriers to participation in re-
habilitation [9, 12, 13], determinants or mechanisms
of effect [14], the outline model was underpinned by
the World Health Organisation International Classifi-
cation of Function Disability and Health, [15] plus
theories of rehabilitation [16] and behaviour change
(see Fig. 1) [17–19].
This outline model of rehabilitation meets the definition
of complexity as defined in the Medical Research Council
framework for the development and evaluation of complex
interventions [20]. Thus, as part of the intervention model-
ling and development, we conducted this qualitative study
to address key uncertainties relating to the model prior to
testing it in a future randomised feasibility trial [21].
Recruiting patients to randomised controlled trials (RCTs)
is challenging, and prospective identification of issues rele-
vant to their successful conduct is recommended [20]. We
therefore aimed to elicit patient, family and clinician views
to further develop and refine the outline rehabilitation
model. We also aimed to elicit factors that may facilitate or
hinder participation in a feasibility trial of a rehabilitation
intervention, including priorities for rehabilitation compo-
nents and processes, trial outcomes valued by patients and
clinicians and potential mechanisms of action. We also
sought preferences for the trial delivery, including how to
align activities with usual oncology and/or palliative care
services.
Fig. 1 Outline rehabilitation logic model [14]
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Method
Design
This qualitative study sits within the development phase of an
overarching sequential exploratory mixed-methods project. It
is reported in accordance with the consolidated criteria for
reporting qualitative research (COREQ) guidance [22] [see
Additional file 1]. Focus groups were conducted with an
action-focused pragmatic design. This methodology provided
an efficient, economical method for obtaining participants’
views on health services where individual phenomenological
data were not required [21, 23]. The facilitated group discus-
sions promoted interactions between participants, allowed re-
searchers to interact and respond to participants’ comments
and potentially revealed richer and clarified data compared to
individual interviews or questionnaires [24, 25]. Being part of
a group discussion may also have improved respondent’s will-
ingness to share their views [26].
Participants and setting
Purposive sampling was used to obtain views from across
two target groups; the first included those living with thor-
acic cancer (any primary lung cancer or pleural mesotheli-
oma), informal carers, and members of patient support
organisations focusing on thoracic cancer, and the second
included oncologists, chest physicians, lung cancer and
palliative care clinical nurse specialists (CNS), allied health
care professionals (AHPs), social workers and psycholo-
gists with an interest in thoracic cancer. We aimed to re-
cruit 12–15 participants from each population group (30
in total). Given the focused nature of our study within this
specified population, the communication skills of the
focus group facilitators and the cross-sectional nature of
our analysis plan, we considered that this sample size
would provide sufficient “information power” [27] to meet
the aims of the study within a pragmatic time frame. We
expected to undertake three focus groups per population
group due to the logistical constraints experienced by cli-
nicians and patients undergoing investigations and treat-
ments. We did not intentionally seek data saturation [28].
Participants were invited to participate via public ad-
verts, distributed via patient support organisations, can-
cer information centres, clinical special interest groups
and oncology and rehabilitation services in the sites (one
site in the Midlands and two in the London region, UK)
planned for the randomised feasibility trial. Participants
had to be willing to travel to a study venue and join a
group discussion in English (via interpreters if available)
for approximately 90 min. Travel costs were reimbursed,
but no payment was provided for participation. Patients
treated with radical surgery were excluded as the initial
intended focus of the intervention was on patients on a
non-curative treatment pathway, who represent the ma-
jority of people with thoracic cancer.
Data collection
A systematic review [11] and discussions within the re-
search team and a patient and public involvement (PPI)
forum informed the development of the topic guide (see
Additional file 2). Prior to attendance, participants were sent
and asked to consider four short written patient stories,
based on the literature and the first author (JB’s) clinical ex-
perience as a palliative care physiotherapist. These featured
patients with varied functional impairments and concerns,
to highlight the range of need in people with lung cancer or
mesothelioma. They were designed to inform and stimulate
group discussion. Importantly, they provided a mechanism
for participants to discuss hypothetical scenarios, as well as
or instead of their own experience, [29, 30] to help us iden-
tify rehabilitation components and service processes needed
to best support people manage symptoms and remain active
and independent throughout cancer treatment.
During each focus group, two researchers (JB and MM,
BE, SP or MD) facilitated discussions on key components
and strategies that should be included in the rehabilitation
service, how the service should be delivered, including inte-
gration with other services, issues the research team need
to consider when inviting people to join the trial that might
influence their decision to participate and domains for trial
outcomes. JB and MM are physiotherapists with experience
supporting people with advanced cancer accessing palliative
care services. JB, MM, BE, SP and MD have experienced fa-
cilitating focus groups and interview studies in oncology
and palliative care research. Field notes were taken to allow
for cross-checking with audio-recordings, but were not
used directly in the analysis. All participants were given an
opportunity to ask the researchers questions relating to the
participant information sheet on arrival at the focus group,
prior to written informed consent. The researchers had no
prior relationship with patient or informal carer partici-
pants. Recruitment took place between January and September
2017 at three centres, two in London and one in the Midlands.
We did not conduct member checking as extracting individual
participant data from the group data alters the context of the ut-
terances and may alter the meaning [31].
Data analysis
Group discussions were audio recorded, transcribed verba-
tim and analysed using thematic content analysis [32]. Ini-
tial themes with potential to refine components of the
rehabilitation service, trial processes and outcomes were
identified from a preliminary review of the transcripts (JB).
Transcripts were then independently coded line-by-line by
two researchers (JB, BE) and interpreted deductively to ad-
dress the study aims with additional themes interpreted in-
ductively [31]. NVivo 11 software (QSR International) was
used to incorporate discussion content, different perspec-
tives on a topic, and drawing together of themes. Summary
data were analysed and refined following discussion (JB, BE,
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MM, IJH) to identify common and divergent issues. As we
sought participants’ views to inform the core intervention
components, implementation processes and valued out-
comes for a future feasibility trial, sub themes were refined
and final themes were organised under overarching cat-
egories described in the MRC Process Evaluation Guidance
[14, 33]. We sought to develop our theories of change [34],
to improve our understanding of contextual factors and po-
tential mechanisms of effect that may interact with the
intervention and processes during the feasibility trial. These
factors are presented within each section of the results.
Results
Fifty-two people (35 patients and informal carers, 17 clini-
cians) responded to the public advert. Two patient partici-
pants were members of patient support organisations.
Reasons for non-participation included the following: 6
were unable to attend on scheduled date(s), 5 did not reply
to contact following receipt of participation information
leaflet, 5 were unable to travel or not feeling well enough to
attend, 4 were not interested, and 3 were cured of disease
and ineligible.
Twenty-nine participants consented and took part in
eight focus groups ranging from 43 to 77 min, with a
median of 60 min. Due to difficulties convening groups
that all interested participants could attend, and to min-
imise the time that recruited patient participants had to
wait to attend a group, four, rather than the planned
three, focus groups were held with each population
group. Fifteen clinicians (12 females/3 male, 2 oncolo-
gists, 4 physiotherapists, 3 occupational therapists, 3
lung cancer nurse specialists and 1 palliative care nurse
specialist) with all the recruitment sites for the feasibility
trial were represented. Nine patients and 5 informal
carers (9 female/5 male) participated. Of the 9 patients,
6 had a diagnosis of lung cancer and 3 mesothelioma.
One participant was about to commence first-line treat-
ment, one had completed treatment and seven were re-
ceiving maintenance chemotherapy or immunotherapy.
We present participant views that have informed and re-
fined the design of the rehabilitation model [35, 36]. Nine
themes are organised under three MRC Process Evalu-
ation categories: (i) components of intervention, (ii) imple-
mentation of trial and intervention and (iii) outcomes.
Factors relating to context and mechanisms of action are
discussed within these three categories below and are pre-
sented separately in Figs. 1 and 2 that show the outline
and refined rehabilitation model respectively.
(i) Components of the rehabilitation intervention
Divergence was observed between patient/carer and
clinician respondent views regarding the purpose of
rehabilitation. Patients and carers emphasised that
their main concerns following diagnosis were to get
on with “normal life”, and they discussed how re-
habilitation could help them “keep going”. Clinicians
supported these aims but prioritised symptom man-
agement and physical activity as a means to support
people to cope with oncology treatment, increase
treatment options, and help patients complete a full
treatment course and cope better with side effects.
Despite this, responses from both groups confirmed that
while the core components of the outline model (Fig. 1)
should be retained (supporting usual activities; tailored
symptom management and physical activity ± exercise), re-
finements were needed to maximise its acceptability to pa-
tients in the contextual period following diagnosis. It was
recommended that although individual participants may
need varying combinations of these components, an over-
arching educational and motivational approach were im-
portant components and potential mechanisms of action
for everyone (see Fig. 2).
Supporting usual activities
Patients and carers recommended that intervention compo-
nents help people address the impact of diagnosis and the
effects of treatment on their normal life, rather than as a
means to complete oncology treatment. They described the
devastation and shock of diagnosis that can be a major
threat to usual roles and activities. Components should
help them feel safe and reduce concerns that they
may do themselves harm. Even previously fit people
may struggle to maintain normal routines and activ-
ities on hearing they have an illness they associate
with death.
“…the other really important thing is to just keep your
life... as normal as possible. I don’t know if a lot of
people are managing that.” (PFG08 patient)
“…some people, I know of several, when they were
diagnosed, they just gave up completely. One guy just
sat in the chair, you know, wanting to die. His wife
was distraught, because he’d been a very active
person, so everybody reacts differently to the
diagnosis.” (PFG04 patient)
This was also valued by clinicians who recognised such
concerns exist and are not always addressed during
clinic appointments, which focus on treatment planning.
“They don’t always tell us everything when they come
into clinic. They’re just focused on discussing about
chemotherapy, not everything. I feel that a lot of
them, they don’t tell us. If we provide extra support
and services I think they might just come out and tell,
Oh, this is a problem I’m facing at home” 13, line.
(CFG11 oncologist)
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Tailored symptom management
In considering the aims for rehabilitation, participants
reported that symptom management components must
be tailored as the impact of symptoms on individuals
varies considerably. Responses demonstrated that phys-
ical and psychological symptoms may precede diagnosis
and impact on all aspects of daily life. Some reported
feeling well initially, only developing symptoms during
oncology treatment. Others were initially symptomatic,
but symptoms resolved quickly following the start of
treatment. The diversity highlighted the need for a de-
tailed functional assessment and a personalised approach
to support individuals to maintain participation in their
normal roles and routines. Although functional limita-
tion is highly prevalent at diagnosis in thoracic cancer, it
should not be assumed.
“My fatigue started before my diagnosis. It started off
with a dry cough, which just lasted for months and it
didn’t go away. I started, you know, getting more and
more fatigued. I couldn’t walk for more than a few
yards without stopping for breath.” (PFG05 patient)
I couldn’t walk the kids to school, I couldn’t even
walk to the end of the road really. Even walking
upstairs was… you know and having breathing
problems, you do panic sometimes. You can’t get your
breath and it is trying to calm yourself down,
especially if the kids are in the room and you don’t
want to scare them. (PFG12 patient)
Management strategies should meet immediate needs
when symptoms are present, but be offered alongside as a
preventative approach. Patients, clinicians and carers
agreed it was important to offer advice and training in an-
ticipation of common experienced symptoms, as this may
decelerate the impact of the disease, improve coping and
reduce distress. This preventative approach was consid-
ered particularly important for people who either do not
have symptoms, or where symptoms have responded to
treatment but may reoccur.
Strategies discussed included advice and support for
ongoing daily activity, general physical activity, exercise
and dietary advice. Participants highlighted the physical
symptoms of weakness, fatigue, breathlessness, weight
loss, cough and pain, but also recommended that com-
ponents address the psychological symptoms such as de-
pression, anxiety and worries for the future.
“I think when you’re first diagnosed with cancer, all
these symptoms that you’ve all talked about, if it’s not
been explained to you that these are the feelings. But
Fig. 2 Refined rehabilitation logic model [14]
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you see somebody like a physiotherapist or whatever,
that can explain this to you and show you exercises
that you can do at home to make you feel better, to
make you feel you’re achieving something.”
(PFG09 patient)
I’ve found that anxiety is quite high in a lot of those
patients. Depression can be quite a prevalent
symptom as well, but I think anxiety is the biggest,
probably one of the biggest things you see at that
stage. It impacts upon everything they do, simple
things. They sometimes can’t do the simplest things
because they’re worrying about what’s going to
happen. (CFG08 AHP)
Optimising physical fitness
Participants recommended that rehabilitation should expli-
citly raise the importance of physical fitness and activity to
help people cope with symptoms and treatment. Although
this needs to be tailored, respondents considered it import-
ant to offer this to all patients, not just those with higher
levels of fitness pre-diagnosis. Reflecting on their own expe-
riences, patient participants thought that the language of
fitness may foster hope at a time when much of the news
being received is distressing, and may therefore improve
the acceptability of the service.
Divergence on the role of fitness components was ob-
served between clinicians and patient or informal carer par-
ticipants. Clinicians emphasised the importance of
optimising physical fitness for treatment and that improving
it could expand options and increases completion rates.
“You’ve been given this diagnosis. We want to support
you, so that you are well enough and as fit as you can
be to go through whatever treatment they offer you,
whatever that may be,” would be a good first step,
because it would also maybe take their mind a little
bit off the diagnosis and allow them to see the bigger
picture. (CFG12 oncologist)
In contrast, patients and carers had not considered that
participation may improve treatment outcomes. They recog-
nised value in terms of promoting participation in everyday
activities and tasks and carrying on with interests; indeed,
those who had exercised were able to recall functional bene-
fit. They recognised some people may find it hard to think
about fitness at diagnosis, and small changes in behaviour,
e.g. avoiding unnecessary rest, may be more achievable.
“It helps boost your whole system. You’re going to be
less tired if you’re more active because the more you
sit back and lay down, then you’re just going to get
much weaker.” (PFG10)
A motivational approach
Patients and carers raised the importance of the attitude
and behaviour of the health care professional delivering
the service. As well as having insight and expertise to sup-
port people in distress, they need skills to encourage reluc-
tant or poorly motivated people to participate. Family
were also recognised as providing motivational support
and participants recommended that trial participants are
offered to invite a family member to be present during the
intervention.
“You’ve got to tell me and you’ve got to keep
prodding and getting me there. I might say, “I don’t
want you, I don’t want you”, but I do. I realise I do.”
(PFG06 patient)
“It is so easy just to sit there, go off to your
treatments, come back home, sit there and [spouse]
really encouraged me… “Why don’t you get up and do
something, get everything working again”. I think I
needed that push really, in the right direction.”
(PFG12 patient)
Participants described that beliefs about cancer and
its treatment cause some patients and their families
to lose confidence to be active. They potentially limit
themselves, even in situations where they may re-
spond well to treatment and have months, if not
years, to live. Participants recommended that profes-
sionals should recognise and sensitively address these
beliefs to maximise engagement with the intervention
components.
“One lady who, after her diagnosis, went home, wrote
a will, gave up her job, started preparing for end of
life, when actually two years down the line she’s still
here with us.” (CFG03 CNS)
All participants recognised that some individuals need
more encouragement than others to participate and that
some would not be interested in rehabilitation.
“I think if you are in a palliative situation, it feels as if
there’s more to take in, and there’s the, “Well, why
bother?” kind of attitude, quite often, and overcoming
that takes a bit of time.” (CFG12 oncologist)
Participants also described that multiple hospital
and treatment appointments may influence how
much time people felt they could give to
participating in rehabilitation. They considered that
self-management strategies are more likely to be
used if they target meaningful priorities or goals and
can be flexibly tailored to fluctuating health states.
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“I have to be in the hospital all the time. I cannot go
to work and I’m self-employed, do you understand?
So all those things are changing. You lose everything
in your head…You actually lose your confidence.
(PFG11 patient)”
Promoting participants’ motivation and self-confidence
was considered important, but strategies should be real-
istic in their scope. Some patients demonstrated resili-
ence and were using self-directed strategies to manage
symptoms and maintain fitness. In these situations, sim-
ple practical advice or affirmation of their own strategies
may be all that is needed from a rehabilitation service.
…gentle exercise to keep you going and then maybe
have another visit from physio or whatever and say,
“Right, I have achieved this, I’ve done my 10,000 steps
or whatever it is a day”. They say, “Right, that’s
brilliant. So let’s up it then to 20,000 steps or try
doing this...”. Encouraging them but pointing out...
what you can do, what’s available for you to do to
keep you fit. (PFG09 patient)
(ii) Trial and intervention implementation
Trial screening and recruitment
When considering inviting people to join the feasibility
trial, participants described that timing and manner of
approach is important to consider. As described above,
initial responses to diagnosis may be dominated by feel-
ings of shock, distress and thoughts of death. It was
agreed by all participants that usually, it would not be
appropriate to introduce the trial on the day patients re-
ceive their diagnosis, when they may be overwhelmed
trying to absorb large amounts of information and make
decisions about treatment. Soon after this, appointment
was preferred, with timing tailored to individual context.
For those receiving their diagnosis as an outpatient, the
subsequent appointment was preferred. Participants
could see the advantages of waiting until treatment was
planned. However, as the waiting period between diag-
nosis and treatment can be prolonged (several weeks),
some patients may gain benefit from receiving rehabilita-
tion before oncology treatment commences. Participants
felt that screening contact and recruitment contacts
could be made sooner if participants were diagnosed
during an in-patient admission.
“…if it can improve your fitness during that period
they might cope with the chemotherapy better.
Patients are sitting at home thinking, ‘I haven’t started
any treatment’. They’re worried. They always keep on
thinking that they haven't started anything.”
(CFG11 oncologist)
“I’m not absolutely sure that the first time that you
attend for a consultant appointment, when you’ve got
all other things on your mind, that that is necessarily
the best time to be asked whether you want to join in
all these things. You can’t put it into a context.”
(PFG02 carer)
Linked closely to timing, the manner of approach was para-
mount for patients and their families. Some reported that ini-
tially they could only think about telling family members or
getting things in order at home and preparing for death and
may not have perceived the relevance of rehabilitation. They
wanted those involved in screening and recruitment to
present information about the service and the trial sensitively,
demonstrating understanding about each person’s situation
and discussing the trial in relation to how it might help them
in their situation. Clinicians felt it was important to promote
that the intervention as helping people get fit for treatment.
“Like [other participant] mentioned earlier, it’s about
the manner. There should be a certain way to sit
down with people and explain to them, because
you’ve already given them really, really bad news. So if
you could also explain to them in an educational way
so that you don’t make them feel anymore worse than
they already do. That will be quite helpful.”
(PFG10 carer)
“I think after a decision has been made what
treatment they want to go for, then having another
session saying, Okay, you’ve decided to go for that
treatment. Let’s get you as well as you can, so that you
can go through that treatment and maintain your
independence.” (CFG12 Oncologist)
Participants reported patients may feel overwhelmed with
information at diagnosis that is hard to absorb, especially
written information which may get put away, unread. They
recommended that information about the trial be paced
and tailored to each person’s readiness to engage. Some pa-
tients and carers reported that they did not understand the
need for the rehabilitation model to be trialled in a con-
trolled manner, and that they would not have wanted to be
allocated to care as usual. Others recognised that a trial
may ascertain if the rehabilitation offers additional benefit
to oncology treatment. On discussion, they recommended
that a clear explanation of the reasons for randomisation
should be provided in all trial information.
“It’s going to work anyway. It’s obvious, if someone is
lying in bed ill and then someone is getting up and
doing exercise, they are going to benefit from it. I
don’t think you need to trial it. (PFG06) I’m with you
there…yes.” (PFG08)
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Despite the challenges in making the initial approach to
potential participants, clinicians, patients and carers consid-
ered that the patients should be offered participation in the
trial in the period following diagnosis, rather than waiting
for first oncology treatments to be completed. Clinicians
highlighted the value of delivering early rehabilitation to
optimise fitness and well-being. They suggested tailoring in-
formation about the trial to individuals’ current health sta-
tus. For those without functional needs, the trial could be
presented as testing an intervention that aims to get people
fit for treatment. For those who are unwell, the trial could
be presented as testing an intervention to help people man-
age the symptoms and limitations.
With the benefit of hindsight, patients described how
the changes in their health status between diagnosis and
treatment may have impacted on their engagement with
a trial. Some, who felt well at diagnosis and did not an-
ticipate how they would feel once treatment started, re-
ported they may have declined to participate later on.
Those whose health condition was deteriorating rapidly
at diagnosis reported that whilst they may have declined
to participate in a strenuous exercise intervention, they
were open to an intervention to meet their immediate
needs or feel more positive about their future.
“I think you would have struggled to listen to
someone telling you to be active at that stage. You
just couldn’t could you? (PFG013 carer) But the
information I did get I think was really good from the
guy. (PFG012 patient) Oh, the breathing and that,
yes.” (PFG013 carer)
We had planned to include only patients with inoper-
able disease. However, clinical participants reported that
patients having surgery would also benefit from this type
of rehabilitation model. They recommended an inclusive
eligibility criterion that includes patients on any oncol-
ogy or palliative care treatment pathway.
“Then the people after surgery might struggle as well.
I can’t understand why one group is in, it all and not
the other, the one on chemo-radiotherapy. I think …
involve everybody”. (CFG11) “Absolutely do, yes.”
(CFG09 CNS)
Intervention delivery
The strongest message to come from all participants was
for a flexible rehabilitation service, integrated with sched-
uled hospital and oncology treatment appointments. This
requires the model to be tailored around participants’
schedules, their health state and preferences. Necessities,
such as the need to continue working or look after family,
require some patients to continue with usual roles and
responsibilities. Clinicians reported an increase in “never
smoked” working adults, some caring for children. Three of
the patient participants were caring for school age children.
A flexible approach to service delivery may improve acces-
sibility for patients with family commitments.
“I kind of didn’t change my routine. I mean I’ve got
three small children… You don’t know what to think,
but I went into action. I thought I’m not going to let
this conquer me. I’m stronger than this. I’m going to
fight this.” (PFG08 patient)
To maximise inclusivity, the rehabilitation should be
offered to participants in the location of their preference,
which may be a hospital, at a schedule appointment, or
in their own home. Participants and clinicians spoke of
the boredom experienced by patients attending multiple
appointments, waiting for hours in clinic or on treat-
ment. Participants would prefer to receive the rehabilita-
tion during these waiting times than come back for
additional appointments. For others, travel itself was
burdensome due to distance or overall health, and in
these circumstances, home was the preferred location.
Additionally, some patients and carers felt they would
find it easier to learn rehabilitation techniques in their
home environment. They considered that this flexibility
would maximise participants’ willingness to join and re-
main on trial.
“I would say the vast majority of patients voice to us
that they don’t want to come up any extra. I don’t
think you will get them turning up unless it is on a
day that they have already got an appointment. That
is a big one.” (CGF06 AHP)
“…if someone was to approach you when you’re
sitting there waiting for that oncologist. Is hours we’ve
sat in waiting rooms. (PFG06 patient) It’s tiring as
well, so if you’re kept busy then it’s not going to be
that bad.” (PFG10 carer)
Clinicians felt that the proposed three contacts were
appropriate and these were sufficient to address peoples’
functional needs following diagnosis without adding
additional undue burden. Patients and carers were more
concerned with not returning to the hospital for extra
appointments than the number of contacts received dur-
ing the intervention. However, they reported that some
patients may want more prolonged involvement with re-
habilitation services. Patient participants were happy
with the proposed plan for referral to ongoing services,
but were unsure about where or what these may be. Cli-
nicians were also concerned about the availability of ser-
vices for onward referral.
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Outcomes
Patient centred
All participants recognised the challenges of measuring the
impact of the service where the natural course of the disease
and overall health state in participants will be varied and un-
predictable. Consequently, objective measures of fitness
were not considered useful in such a broad target
population.
“…it is so hard because of the population group. That
is the thing because, you know, they just fluctuate so
much, so getting any standardised assessment unless
you are measuring something like their confidence in
doing a task.” (CFG06 AHP)
Instead, participants recommended patient-reported out-
come measures that assess changes in levels of symptom dis-
tress, physical activity, and function alongside confidence to
perform daily activities and to manage symptoms. Clinicians
also recommended using a quality of life measure.
“Perhaps they could have like a pre questionnaire,
what does your daily routine involve today and then a
follow up, what does your routine do today and
compare them.” (PFG07 carer)
“rather than it being an actual symptom that may get
better or get worse, it’s their confidence in managing
their symptoms …a lot of it will be around them just
feeling that they’ve got the skills, they’re equipped to
manage on their own.” (CFG02 AHP)
Intervention process
All participants recommended measuring the nature and
number of rehabilitation components, the frequency, mode
and location of contacts, as well as experience and satisfac-
tion with rehabilitation.
“I would think that, probably the group that felt it was
not doing them any good would tend to start staying
away.” (PFG05 patient)
Oncology treatment related
In addition to the number of participants joining and
completing the trial, clinicians recommended assessing
whether oncology treatments were received as planned,
reasons for discontinuing treatment, treatment toxicity
scores, unplanned hospital admissions and use of other
health care services during the trial period.
They might have, I think, better tolerance for the
treatment as well. I think they can tolerate better if
they’re well supported psychologically and so on.
Those kinds of things we include, the hospital stay,
for example, what is their outcome and whether we
had to reduce the dose of chemotherapy and so on, all
those things we can do. (CFG11 oncologist)
“I don’t know if there are any independence scores
that assess how independent patients stay, and
compare that with the toxicity profile that we get
from the chemotherapy, so you can see that patients
react differently to the chemotherapy?”
(CFG12 oncologist)
Discussion
We conducted focus groups to develop and refine a com-
plex intervention and procedures for a future randomised
feasibility trial. The findings have illuminated factors to be
refined in the conduct of a planned trial in this population.
Implications include an improved understanding of con-
textual factors and mechanisms of action relating to inter-
vention components, specific trial processes, and the
selection of feasibility and clinical outcomes. The findings
redirect the focus of the rehabilitation model towards help-
ing people stay active and independent as they commence
treatment by addressing beliefs, symptoms and psycho-
logical concerns that limit participation in daily life. Inter-
vention components should include strategies to address
needs in patients across the age range and with varying per-
formance status. Recognising that people are often over-
whelmed at diagnosis, information given should be
individualised and brief, with strategies focused on immedi-
ate needs. The service should work towards meaningful
goals, including improved capacity to tolerate oncology
treatments. For people who feel well and have higher levels
of fitness, a positive training approach should support
people maintain independence and get the most from
planned oncology treatments. This pro-active approach
should seek to improve participants’ self-confidence to cope
and address illness understandings, belief and fears that im-
pact on function. It should support ongoing participation in
usual activities and reduce sedentary time to maintain inde-
pendence and fitness. This study confirms findings from
previous research that patients place importance on how
interventions are delivered [37]. Encouraging and support-
ing usual habitual activities wherever possible should align
with patients’ desires to keep life normal, to not feel ill. Tai-
lored exercise strategies can be added for those who are
motivated. Strategies to manage common symptoms should
be offered to all patients. This should provide immediate re-
lief for those experiencing symptoms and include preventive
and proactive strategies for those at risk of developing them
during or following treatment. Previous rehabilitation stud-
ies in this population group have focused on discrete
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interventions, such as breathlessness management or exer-
cise to address impairments [11]. However, beliefs pertain-
ing to potential harm may preclude participation in
rehabilitation, including exercise [9, 12, 13]. If symptoms
are not present, people may see no value in participating in
symptom self-management [10, 38].
Our findings corroborate findings of previous qualitative
studies. The intervention and the trial processes should be
flexible, integrating with usual oncology services to reduce
the barriers that arise when patients are required to attend
additional hospital appointments [9, 10]. Home-based ap-
pointments may improve recruitment and retention. Our
trial eligibility criteria were refined because of the focus
groups. The trial should recruit patients on any treatment
pathway to maximise recruitment but also provide equit-
able care. The importance placed on the interpersonal attri-
butes of the researchers has implications for all members of
a feasibility trial research team. Those involved in screening
should approach potential participants with sensitively, with
an understanding of their unique context. Information
about the trial can be paced during the screening and in-
formed consent process, using a one-sided summary flyer,
followed by the full participant information leaflet for those
requesting further information.
Clinical outcomes should focus on domains meaning-
ful to the varying needs of patients.
Process outcomes should include treatment comple-
tion rates, important to clinicians and patients. Although
challenging, our findings suggest that delivering inter-
ventions following diagnosis, is warranted [39–41], and
we, like others, [42] suggest that integrating into existing
services and modelling services with close involvement
of all involved will facilitate future practice change.
Our initial development work for the trial intervention
was underpinned by models and theories of rehabilitation
[16] and behaviour change (The Behaviour Change Wheel
[17], Intervention Mapping [18] and Implementation
Intention Planning [19]). However, our findings suggest that
these theories alone may not have the best “ecological fit”
[35] in the context of a new diagnosis of thoracic cancer.
Importantly, these theories may not illuminate potential
mechanisms of action relating to the sudden change in cir-
cumstances or uncertainties experienced by patients and
their families. As a result, the intervention likely has a re-
duced scope of action.
Theories of illness provide explanations for contextual
factors such as the tensions experienced by patients who
want to remain well and continue with normal life yet
struggle to prioritise rehabilitation. Reorientation of
self-identity and adjustment takes effort and time, varying
depending on the context of each person and the approach
taken by the clinicians providing their care [43–45]. The
manner of approach and the focus of rehabilitation contacts
should be context sensitive and tailored, addressing all
possible mechanisms of action, including those relating to
experiences of illness. These will include the “immediacy”
[44] of participants’ current life experience, their pressing
needs, concerns and beliefs following diagnosis. Use of ill-
ness theory will support refinement of the rehabilitation
model so these factors are addressed in the intervention de-
sign, implementation and evaluation.
Strengths and limitations
The focus group study has refined the underpinning theory,
design and implementation processes of a rehabilitation
model for testing in a future feasibility trial [46]. Participants
were recruited from all proposed trial sites and clinical
groups who will be referring patients to the trial. We re-
cruited patients (with diagnoses of both lung cancer and
mesothelioma) and informal carers with a diversity of ages
and life situation. The interaction between participants gen-
erated rich data concerning the variation in performance
status, impairments and functional expectations present in
this population. One limitation in our sampling is the possi-
bility that only fitter patients interested in rehabilitation were
recruited. They may not represent views of people who are
more unwell. However, participants reported experiences of
patients with lower levels of fitness and motivation and this
has influenced our planned screening strategies and the
intervention components. Challenges were experienced get-
ting participants to focus groups on the same day resulting
in two patient focus groups of three participants and one
with two, which potentially limited participant interaction
[28]. However, in these cases, participants engaged with each
other and revealed unique perspectives not discussed in lar-
ger focus groups. Again, these contributed to the develop-
ment of the themes during analysis. The action orientated
pragmatic nature of this study meant we did not analyse la-
tent themes [32] or consider wider structural issues which
may impact on the implementation and outcomes of the
intervention [47]. However, the findings have broadened our
theoretical perspective and improved our rehabilitation
model to improve the quality and evaluation of the planned
randomised feasibility trial (ISRCTN92666109).
Conclusion
The focus group findings provide insights for the develop-
ment of rehabilitation interventions in patients with lung can-
cer and mesothelioma, which were used to refine the
intervention content and delivery, working processes and tar-
get outcomes for a future feasibility trial. The rehabilitation
intervention builds on the findings of earlier studies and is
modelled using patient, carer and clinician views around de-
livery. It is inclusive, addresses a range of functional limita-
tions and aims to integrate with oncology services. Beyond
these direct implications, our findings can help inform the
development of pro-active rehabilitation interventions in
other populations newly diagnosed with advanced disease.
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